[Utility of linezolid in cystic fibrosis].
Girón-Moreno
Rosa María
RM
Ruiz-Velasco
Luis M
LM
Buendía
Ventura
V
D000081:Acetamides / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000890:Anti-Infective Agents / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D002442:Ceftazidime / Q000627:therapeutic use; D002908:Chronic Disease; D003550:Cystic Fibrosis / Q000150:complications*; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D000069349:Linezolid; D008297:Male; D023303:Oxazolidinones / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000209:etiology; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000209:etiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D014031:Tobramycin / Q000627:therapeutic use
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D002442:Ceftazidime; D000069349:Linezolid; D014031:Tobramycin